PTC Therapeutics Inc PTCT

NAS: PTCT | ISIN: US69366J2006 26/03/2026

67,00 USD (+0,37%)

(+0,37%) 26/03/2026

Grafiek PTC Therapeutics Inc

Grafiek PTC Therapeutics Inc

1 dag1d 0,37%
1 week1w 2,60%
1 maand1m -1,75%
3 maanden3m -13,70%
6 maanden6m 10,47%
1 jaar1j 21,84%
5 jaar5j 39,41%

PTC Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

25 maart 2026 · PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors · Persbericht

13 maart 2026 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

23 februari 2026 · PTC Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

19 februari 2026 · PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results · Persbericht

12 februari 2026 · PTC Therapeutics Provides Regulatory Update on Translarna™ · Persbericht

5 februari 2026 · PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 · Persbericht

12 januari 2026 · PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference · Persbericht

8 januari 2026 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

22 december 2025 · PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan · Persbericht

19 december 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

Profiel PTC Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.ptcbio.com

Hoofdzetel: South Plainfield, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe